Show simple item record

dc.contributor.authorValero Juan, Margarita 
dc.contributor.authorCarrillo, Carmen
dc.contributor.authorRodríguez Hernández, Licesio Jesús
dc.date.accessioned2026-04-17T10:49:47Z
dc.date.available2026-04-17T10:49:47Z
dc.date.issued2003
dc.identifier.citationValero, M., Carrillo, C., & Rodríguez, L. J. (2003). Ternary naproxen:β-cyclodextrin:polyethylene glycol complex formation. International Journal of Pharmaceutics, 265(1-2), 141-149. https://doi.org/10.1016/J.IJPHARM.2003.07.003es_ES
dc.identifier.issn0378-5173
dc.identifier.urihttp://hdl.handle.net/10366/171030
dc.description.abstract[EN]The aim of this study was to investigate the effect of the presence of the water-soluble polymer polyethylene glycol (PEG)—MW=35000 g/mol—on the complexation of the phototoxic anti-inflammatory drug naproxen, in its sodium salt form, with β-cyclodextrin (β-CD). The data revealed that the polymer does not interact with the uncomplexed naproxen whereas it does with the β-CD. The presence of different proportions of PEG, in the 0–1% (w/w) range, systematically lowers Kapp of the formation of the naproxen:β-CD inclusion complex. The reason for the decrease in the complexed drug is the presence of other competing equilibria, the first one is an interaction of the polymer with the β-CD, which in turn reduces the amount of free CD available for including the naproxen, and the second is the formation of a naproxen:β-CD:PEG ternary complex with lower affinity than the binary complex. The binding constant of these processes are K2=(4.5±1.0)×105 M−1 and K3=870±19 M−1, respectively. In addition the presence of the PEG produces an important change in the driving force of the complex formation. In this case the process is enthalpically unfavoured and entropically favoured; these are typical characteristics of processes governed by hydrophobic interactions.es_ES
dc.format.mimetypeapplication/pdf
dc.language.isoenges_ES
dc.publisherElsevieres_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacionales_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/es_ES
dc.subjectNaproxenes_ES
dc.subjectPolyethylene glycoles_ES
dc.subjectβ-cyclodextrines_ES
dc.subject.meshNaproxen *
dc.subject.meshPolyethylene Glycols *
dc.titleTernary naproxen:β-cyclodextrin:polyethylene: glycol complex formationes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publishversionhttps://doi.org/10.1016/J.IJPHARM.2003.07.003es_ES
dc.identifier.doi10.1016/J.IJPHARM.2003.07.003
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES
dc.journal.titleInternational Journal of Pharmaceuticses_ES
dc.volume.number265es_ES
dc.issue.number1-2es_ES
dc.page.initial141es_ES
dc.page.final149es_ES
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones_ES
dc.subject.decsglicoles de polietileno *
dc.subject.decsnaproxeno *


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 Internacional